Aventusoft (NSF-1456401) develops medical devices to improve early detection and monitoring of heart disease. The company’s product “Hemotag” is designed to help doctors avoid invasive procedures when evaluating a patient. The device provides non-invasive, 30-second measurements to assess structural heart health. Article via Refresh Miami